Goldenwell Biotech (GWLL) Gross Profit (2021 - 2025)

Goldenwell Biotech has reported Gross Profit for 5 years, with the latest figure at $25000.0 in Q3 2025.

• For the quarter ending Q3 2025, Gross Profit changed N/A year-over-year to $25000.0; the trailing twelve-month figure through Sep 2025 stood at $62415.0 (up 43546.85% YoY), and the FY2024 full-year result was $64.0, down 90.39% from the prior year.
• Gross Profit for Q3 2025 stood at $25000.0, down from $37500.0 in the prior quarter.
• The five-year high for Gross Profit was $37500.0 in Q2 2025, with the low at -$85.0 in Q4 2024.
• Historically, Gross Profit has averaged $7023.6 across 5 years, with a median of $646.0 in 2021.
• Annual changes were most pronounced in 2024 — Gross Profit sank 216.44% — and 2025, when it jumped 53471.43%.
• Goldenwell Biotech's Gross Profit stood at $2578.0 in 2021, then soared by 793.25% to $23028.0 in 2022, then tumbled by 99.68% to $73.0 in 2023, then slumped by 216.44% to -$85.0 in 2024, then surged by 29511.76% to $25000.0 in 2025.
• The last three Gross Profit figures came in at $25000.0 (Q3 2025), $37500.0 (Q2 2025), and -$85.0 (Q4 2024), per Business Quant data.